Cross-sectional Group Sessions


If your interests are not easily defined by just one section, consider these Cross-sectional platform sessions.

(all times shown are PT)

Tuesday, May 7
8:30 - 10:15am

Virtual and augmented reality for low vision (LV)

Over the past decade, advances in image processing techniques and display technology have led to the emergence of augmented reality (AR) and virtual reality (VR)-based low-vision devices. Because they allow to update and optimize the visual stimulus depending on the user’s eye, head or body movements, wearable AR/VR devices may allow to efficiently enhance residual vision. Therefore, they hold tremendous potential as an assistive technology for individuals with low vision. However, their true promises and limitations in low-vision care and rehabilitation are not fully identified yet. The objective of this symposium is to give a crisp overview of the available technology, addressing accessibility and assistive tech for people who are visually impaired. Speakers will present their latest research on the topic, highlighting the strength and current shortcomings of wearable AR/VR technology applied to low vision.

Wednesday, May 8
10:30am - 12:15pm


How statistical genetics can lead to improved therapeutics and patient care (GEN)

The completion of the first blueprint of the human genome at the beginning of this century and advances in genotyping and sequencing technologies paved the way for increasingly powerful statistical genetic studies that discovered much of what we know today about the relationship between genes and phenotypes in health and disease. Almost two decades after the first genome-wide association study, this symposium will provide a cleared-eye look into the degree to which genomics is fulfilling its promise to transform therapeutic design, patient care and public health now and in the future.